Dariohealth announces $14.3 million private placement

Newly designated convertible preferred stock priced at the market under nasdaq rules with significant participation by select members of leadership, the board and existing investors company also announces refinancing of $25 million borrowed funds, saving approximately $6 million in annual amortization payments proforma cash balance as of the end of q1 inclusive of the private placement funds and the refinanced loan is $60m new york , may 2, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, today announced the pricing of a $14.3 million private placement of convertible preferred stock, priced at the market under nasdaq rules, with significant participation by select members of leadership, the board and existing investors. the company also announced the re-financing of its existing credit facility.
DRIO Ratings Summary
DRIO Quant Ranking